Global Pharmaceutical Industry Trade Balance by Country

In 2023, Ireland led the global pharmaceutical industry trade balance with a value of $93.33 billion, showing a significant year-on-year variation of 17.7%. Switzerland followed with a trade balance value of $70.48 billion, marking an 8.19% increase from the previous year. The United States, meanwhile, had a substantial negative trade balance of -$85.03 billion, indicating a major dependence on pharmaceutical imports.

Countries such as Germany, Belgium, and Italy maintained stable trade balances with no significant variation, reflecting mature and consistent pharmaceutical industries. Conversely, countries like China and Russia continued to experience substantial negative trade balances, highlighting a considerable gap between domestic production and demand.

Looking ahead, key trends to watch include the potential increase in trade balance for emerging pharmaceutical markets, the impact of advancements in biotechnology on trade flows, and the ongoing influence of health policies and trade agreements on global pharmaceutical trade dynamics.

Top countries in Pharmaceutical Industry Trade Balance by Country

# 10 Countries Million US Dollars Last Year YoY 5-years CAGR
1 1 Ireland 93,330 2023 +13.05% +17.7% View data
2 2 Switzerland 70,480 2023 +7.49% +8.19% View data
3 3 Germany 37,700 2023 +3.46% View data
4 4 Belgium 29,200 2023 +26.84% View data
5 5 Denmark 16,380 2023 +4.83% +8.14% View data
6 6 France 6,720 2023 +6.81% +4.61% View data
7 7 Sweden 5,920 2023 +2.08% +4.55% View data
8 8 Italy 4,770 2023 +1.53% View data
9 9 Hungary 948.74 2023 +12.91% View data
10 10 United Kingdom 576.3 2023 +455.26% View data